29-Apr-2015
Congressman Peter DiFazio
US Representative Peter DeFazio today spoke out against a provision buried in trade promotion authority legislation that could help a government or multinational corporation attack state or national laws that require the labeling of genetically engineered foods.
7-Jan-2015
European Commission
As published by the European Commission
16-Jun-2008
Financial Express
The Daiichi Sankyo-Ranbaxy Laboratories deal has come as a shot in the arm for India’s Comprehensive Economic Co-operation Agreement (CECA) negotiations with Japan. Indian pharma companies have been unable to break into Japan, the world’s second largest drug market, due to the country’s stringent sanitary and phytosanitary standards, technical barriers to trade (TBT) and environmental norms.
1-Jan-2008
Economic Times
Unlike India, most Asean countries have a very robust regime of quality and safety standards for products imported into their markets. What that means under an India-ASEAN FTA is that Indian manufacturers, despite having lower entry tariffs into Asean, will still not be able to export their products unless they meet the strict safety and quality regulations of those countries.
25-Apr-2007
FoodNavigator.com
The labelling of genetically modified (GM) goods within Malaysia has come further under the spotlight this week as the industry remains torn between its proposed bio-safety laws and free trade agreements between the US.